Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,797 shares at $27.76 ($300K) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $300k TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.76 | 4,964 | $138K | 45.9% |
| 2 | $27.76 | 4,964 | $138K | 45.9% |
| 3 | $28.18 | 869 | $24K | 8.2% |
| Total | $27.79 avg | 10,797 | $300K | 100% |
| Filing → |
| TARS | SELL | 2021-10-14 | $267K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |
| TARS | SELL | 2021-09-03 | $294K | — | Filing → |